Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Endometrial Neoplasms 12Endometrial Hyperplasia 4Turcot syndrome 1Overweight 1Obesity 1Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometrial Adenocarcinoma 1Carcinoma, Endometrioid 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Tirzepatide 3Methods 3Surveys and Questionnaires 2Resistance Training 2Progestins 2Nutrition Assessment 2Megestrol Acetate 2semaglutide 1atezolizumab 1Yoga 1Therapeutics 1Tablets 1TIC10 compound 1Sampling Studies 1Psychology, Positive 1Patient Navigation 1Neuroimaging 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Hysteroscopy 1Estrogen Replacement Therapy 1Early Intervention, Educational 1Diet, Mediterranean 1Diet Therapy 1Counseling 1Body Weight Maintenance 1Blood Specimen Collection 1Blood Glucose Self-Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity × Medroxyprogesterone Acetate × Gynecologic × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡